1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Myocardial Fibrosis: new trials by email Literature Review of Myocardial Fibrosis trials Research Report on Myocardial Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction Dapagliflozin, Placebo - ST-segment Elevation Myocardial Infarction (STEMI), Diabetes Mellitus | Phase 3 | Unknown | Hospital Clinic of Barcelona | 54 | 2021-05-30 | 2025-02-19 |
Diabetes Mellitus (1) · Heart Failure (1) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Metabolic Diseases (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Necrosis (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1)
dapagliflozin (1)
Hospital Clinic of Barcelona (1)
Spain (1)
Luis Ortega, MD, PhD (1) · Salvatore Brugaletta, MD, PhD (1)
2018 (1)